Deutsche Bank assumed coverage on shares of CVS Health (NYSE:CVS) in a research note issued to investors on Thursday, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $91.00 price objective on the pharmacy operator’s stock.

CVS has been the topic of a number of other research reports. ValuEngine downgraded CVS Health from a sell rating to a strong sell rating in a research report on Tuesday, July 2nd. Morgan Stanley reaffirmed a buy rating and issued a $74.00 target price on shares of CVS Health in a research report on Sunday, August 11th. Mizuho set a $71.00 price target on CVS Health and gave the stock a buy rating in a report on Wednesday, June 5th. Standpoint Research upgraded CVS Health from a hold rating to a buy rating in a report on Wednesday, June 5th. Finally, TheStreet upgraded CVS Health from a c+ rating to a b- rating in a report on Monday. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. CVS Health has an average rating of Buy and a consensus target price of $75.91.

Shares of NYSE:CVS traded up $0.15 during midday trading on Thursday, reaching $64.05. The company had a trading volume of 350,206 shares, compared to its average volume of 7,689,623. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The business’s 50 day moving average price is $59.26 and its 200 day moving average price is $55.85. The stock has a market cap of $82.71 billion, a PE ratio of 9.05, a P/E/G ratio of 1.39 and a beta of 0.85. CVS Health has a 1-year low of $51.72 and a 1-year high of $82.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.19. The business had revenue of $63.43 billion for the quarter, compared to the consensus estimate of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. CVS Health’s quarterly revenue was up 35.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.69 earnings per share. On average, research analysts expect that CVS Health will post 6.96 earnings per share for the current fiscal year.

Large investors have recently modified their holdings of the company. Bay Harbor Wealth Management LLC raised its position in shares of CVS Health by 1,871.4% in the first quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 524 shares in the last quarter. Executive Wealth Management LLC raised its position in shares of CVS Health by 62.4% in the second quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 217 shares in the last quarter. Manchester Financial Inc. acquired a new stake in shares of CVS Health in the second quarter valued at approximately $31,000. Hudock Capital Group LLC raised its position in shares of CVS Health by 54.0% in the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 202 shares in the last quarter. Finally, Tarbox Family Office Inc. raised its position in shares of CVS Health by 74.7% in the second quarter. Tarbox Family Office Inc. now owns 580 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 248 shares in the last quarter. Institutional investors own 76.06% of the company’s stock.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Story: What is the definition of market timing?

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.